본문 바로가기
KERD
논문KCI 등재

비만, 폐쇄성 수면무호흡증과 대사장애

Obesity, Obstructive Sleep Apnea, and Metabolic Dysfunction

1

조회

0

다운로드

3

인용

0

참고문헌

키워드

주제분류기타자연과학

초록

수면은 필수적인 생리적 기능일 뿐만 아니라 인간의 성장, 성숙 및 전반적인 건강을 증진시키는 데 중요한 역할을 한다. 수면과 수면 장애가 대사성 질환에 미치는 영향에 대한 관심이 높아지고 있다. 폐쇄성 수면무호흡증은 일반적인 건강 문제이며, 지난 10년 동안 비만율의 증가로 인해 더 두드러진 대사 질환과 함께 폐쇄성 수면무호흡증의 유병률이 현저하게 증가했다. 폐쇄성 수면무호흡증에 의한 대사성 질환을 유발하는 근본적인 메커니즘은 다인성일 가능성이 높으며, 완전히 밝혀지지 않고 있지만, 염증과 산화 스트레스의 활성화와 식욕 조절 호르몬의 조절장애는 폐쇄성 수면무호흡증 환자에게 나타나는 대사 기능 장애와 비만의 중요한 병리 생리학적 성분으로 나타났다. 본 연구에서는 폐쇄성 수면무호흡증과 대사질환의 연관성에 대한 연구 현황과 폐쇄성 수면무호흡증이 이러한 질병을 유발하는 병리생리학적 메커니즘에 대해 검토하고자 한다. 이를 통해 폐쇄성 수면무호흡증과 비만, 그리고 폐쇄성 수면무호흡증과 대사 기능 장애 사이의 잠재적인 상호작용을 이해할 수 있다.

Abstract

Sleep plays an important role in maintaining overall human health. There is increasing interest regarding the impact of sleep related disorders on metabolic diseases. Obstructive sleep apnea (OSA) is a common health problem, and in the last decade, the emergence of increasing obesity rates has further led to a remarkable increase in the prevalence of OSA, along with more prominent metabolic diseases. Obesity is the strongest risk factor for OSA. However, OSA is also known to cause obesity, suggesting an interaction between OSA and obesity. Although the underlying mechanisms leading to OSA-induced metabolic diseases are probably multi-factorial and are yet to be fully elucidated, the activation of inflammation and oxidative stress and the dysregulation of appetite-regulating hormones have emerged as important pathophysiological components of metabolic dysfunction and obesity observed in patients with OSA. Here, we will review the current state of research regarding the association of OSA with metabolic diseases and the possible pathophysiological mechanisms by which OSA could lead to such diseases. This will enhance our understanding of the potential interactions between OSA and obesity and between OSA and metabolic dysfunction.

참고문헌 (90)

  1. Chooi YC, "The epidemiology of obesity", Metabolism, 92, pp.6~10 (2019)[DOI]
  2. Shin HY, "Recent trends in the prevalence of underweight, overweight, and obesity in korean adults : the Korean national health and nutrition examination survey from 1998 to 2014", J Epidemiol, 27, pp.413~419 (2017)[DOI]
  3. Senaratna CV, "Prevalence of obstructive sleep apnea in the general population : a systematic review", Sleep Med Rev, 34, pp.70~81 (2017)[DOI]
  4. Kim J, "Prevalence of sleep-disordered breathing in middle-aged korean men and women", Am J Respir Crit Care Med, 170, pp.1108~1113 (2004)[DOI]
  5. Dong JY, "Obstructive sleep apnea and cardiovascular risk : meta-analysis of prospective cohort studies", Atherosclerosis, 229, pp.489~495 (2013)[DOI]
  6. Camila Hirotsu, "Obstructive sleep apnoea as a risk factor for incident metabolic syndrome: a joined Episono and HypnoLaus prospective cohorts study", European Respiratory Journal, 52(5), pp.1801150~ (2018), European Respiratory Society (ERS)[DOI]
  7. "Guidelines for polygraphic assessment of sleep-related disorders (polysomnography). American electroencephalographic society", J Clin Neurophysiol, 11, pp.116~124 (1994)
  8. Chervin RD, "Obstructive sleep apnea and related disorders", Neurol Clin, 14, pp.583~609 (1996)[DOI]
  9. "Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The report of an american academy of sleep medicine task force", Sleep, 22, pp.667~689 (1999)
  10. ColinE. Sullivan, "REVERSAL OF OBSTRUCTIVE SLEEP APNOEA BY CONTINUOUS POSITIVE AIRWAY PRESSURE APPLIED THROUGH THE NARES", The Lancet, 317(8225), pp.862~865 (1981), Elsevier BV[DOI]
  11. American sleep disorders association, "Practice parameters for the treatment of snoring and obstructive sleep apnea with oral appliances", Sleep, 18, pp.511~513 (1995)[DOI]
  12. Schmidt-Nowara WW, "Treatment of snoring and obstructive sleep apnea with a dental orthosis", Chest, 99, pp.1378~1385 (1991)[DOI]
  13. Young T, "Risk factors for obstructive sleep apnea in adults", Jama, 291, pp.2013~2016 (2004)[DOI]
  14. Punjabi NM, "Sleep-disordered breathing, glucose intolerance, and insulin resistance : the sleep heart health study", Am J Epidemiol, 160, pp.521~530 (2004)[DOI]
  15. Chang AM, "Aging and insulin secretion", Am J Physiol Endocrinol Metab, 284, pp.E7~E12 (2003)[DOI]
  16. Helaine E. Resnick, "Diabetes and Sleep Disturbances", Diabetes Care, 26(3), pp.702~709 (2003), American Diabetes Association[DOI]
  17. Marshall NS, "Is sleep apnea an independent risk factor for prevalent and incident diabetes in the busselton health study?", Journal of clinical sleep medicine: JCSM: official publication of the American Academy of Sleep Medicine, 5, pp.15~20 (2009)
  18. Reichmuth KJ, "Association of sleep apnea and type ii diabetes : a population-based study", Am J Respir Crit Care Med, 172, pp.1590~1595 (2005)[DOI]
  19. Mahmood K, "Prevalence of type 2 diabetes in patients with obstructive sleep apnea in a multi-ethnic sample", J Clin Sleep Med, 5, pp.215~221 (2009)
  20. Foster GD, "Obstructive sleep apnea among obese patients with type 2 diabetes", Diabetes Care, 32, pp.1017~1019 (2009)[DOI]
  21. Lindberg E, "Sleep apnea and glucose metabolism : a long-term follow-up in a community-based sample", Chest, 142, pp.935~942 (2012)[DOI]
  22. Waist circumference and waist-hip ratio: report of a who expert consultation, "World Health O", World Health Organization, ~ (2011)
  23. Ashwell M, "Waist to height ratio is a simple and effective obesity screening tool for cardiovascular risk factors: analysis of data from the british national diet and nutrition survey of adults aged 19-64 years", Obes Facts, 2, pp.97~103 (2009)[DOI]
  24. Rubinstein I, "Improvement in upper airway function after weight loss in patients with obstructive sleep apnea", American Review of Respiratory Disease, 138, pp.1192~1195 (1988)[DOI]
  25. Ouchi N, "Adipokines in inflammation and metabolic disease", Nat Rev Immunol, 11, pp.85~97 (2011)[DOI]
  26. Farrell GC, "Nonalcoholic fatty liver disease : from steatosis to cirrhosis", Hepatology, 43, pp.S99~s112 (2006)[DOI]
  27. Ogden CL, "Prevalence of overweight and obesity in the united states, 1999-2004", Jama, 295, pp.1549~1555 (2006)[DOI]
  28. Ford ES, "C-reactive protein concentration and cardiovascular disease risk factors in children", Circulation, 108, pp.1053~1058 (2003)[DOI]
  29. Yu YH, "Adipocyte signaling and lipid homeostasis", Circulation Research, 96, pp.1042~1052 (2005)[DOI]
  30. Kadowaki T, "Adiponectin and adiponectin receptors", Endocr Rev, 26, pp.439~451 (2005)[DOI]
  31. Matsuzawa Y, "Therapy insight : adipocytokines in metabolic syndrome and related cardiovascular disease", Nat Clin Pract Cardiovasc Med, 3, pp.35~42 (2006)[DOI]
  32. Suganami T, "Adipose tissue macrophages : their role in adipose tissue remodeling", J Leukoc Biol, 88, pp.33~39 (2010)[DOI]
  33. Feuerer M, "Lean, but not obese, fat is enriched for a unique population of regulatory t cells that affect metabolic parameters", Nat Med, 15, pp.930~939 (2009)[DOI]
  34. Marcheva B, "Disruption of the clock components clock and bmal1 leads to hypoinsulinaemia and diabetes", Nature, 466, pp.627~631 (2010)[DOI]
  35. Van Cauter E, "Metabolic consequences of sleep and sleep loss", Sleep Med, 9(Suppl 1), pp.S23~S28 (2008)[DOI]
  36. Leproult R, "Role of sleep and sleep loss in hormonal release and metabolism", Endocr Dev, 17, pp.11~21 (2010)[DOI]
  37. Lago R, "Leptin beyond body weight regulation--current concepts concerning its role in immune function and inflammation", Cell Immunol, 252, pp.139~145 (2008)[DOI]
  38. Spiegel K, "Brief communication : sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite", Ann Intern Med, 141, pp.846~850 (2004)[DOI]
  39. Chaput JP, "Relationship between short sleeping hours and childhood overweight", obesity : results from the ‘québec en forme’ project, 2006, pp.30, 1080~1085
  40. Jiang F, "Sleep and obesity in preschool children", The Journal of Pediatrics, 154, pp.814~818 (2009)[DOI]
  41. Spruyt K, "Sleep duration, sleep regularity, body weight, and metabolic homeostasis in school-aged children", Pediatrics, 127, pp.e345~e352 (2011)[DOI]
  42. Vgontzas AN, "Does obesity play a major role in the pathogenesis of sleep apnoea and its associated manifestations via inflammation, visceral adiposity, and insulin resistance?", Arch Physiol Biochem, 114, pp.211~223 (2008)[DOI]
  43. Rosmond R, "Stress-related cortisol secretion in men : relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities", J Clin Endocrinol Metab, 83, pp.1853~1859 (1998)[DOI]
  44. Vgontzas AN, "Sleep apnea is a manifestation of the metabolic syndrome", Sleep Med Rev, 9, pp.211~224 (2005)[DOI]
  45. Vgontzas AN, "Elevation of plasma cytokines in disorders of excessive daytime sleepiness : role of sleep disturbance and obesity", The Journal of Clinical Endocrinology & Metabolism, 82, pp.1313~1316 (1997)[DOI]
  46. A. N. Vgontzas, "Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistance", Journal of Internal Medicine, 254(1), pp.32~44 (2003), Wiley[DOI]
  47. Resta O, "Sleep-related breathing disorders, loud snoring and excessive daytime sleepiness in obese subjects", Int J Obes Relat Metab Disord, 25, pp.669~675 (2001)[DOI]
  48. Drager LF, "The impact of obstructive sleep apnea on metabolic and inflammatory markers in consecutive patients with metabolic syndrome", PLoS One, 5, pp.e12065~ (2010)[DOI]
  49. Punjabi NM, "Sleep-disordered breathing and insulin resistance in middle-aged and overweight men", Am J Respir Crit Care Med, 165, pp.677~682 (2002)[DOI]
  50. Kim NH, "Association of obstructive sleep apnea and glucose metabolism in subjects with or without obesity", Diabetes Care, 36, pp.3909~3915 (2013)[DOI]
  51. Vagiakis E, "Gender differences on polysomnographic findings in greek subjects with obstructive sleep apnea syndrome", Sleep Med, 7, pp.424~430 (2006)[DOI]
  52. Amy S. Jordan, "Respiratory control stability and upper airway collapsibility in men and women with obstructive sleep apnea", Journal of Applied Physiology, 99(5), pp.2020~2027 (2005), American Physiological Society[DOI]
  53. C. M. R. Franco, "Obstructive Sleep Apnea Severity Correlates with Cellular and Plasma Oxidative Stress Parameters and Affective Symptoms", Journal of Molecular Neuroscience, 47(2), pp.300~310 (2012), Springer Science and Business Media LLC[DOI]
  54. Villa MP, "Urinary concentration of 8-isoprostane as marker of severity of pediatric OSAHS", Sleep Breath, 18, pp.723~729 (2014)[DOI]
  55. Wang N, "Impairment of pancreatic β-cell function by chronic intermittent hypoxia", Exp Physiol, 98, pp.1376~1385 (2013)[DOI]
  56. Fang Y, "Intermittent hypoxia-induced rat pancreatic β-cell apoptosis and protective effects of antioxidant intervention", Nutrition & Diabetes, 4, pp.e131~e131 (2014)[DOI]
  57. Jan Polak, "Intermittent Hypoxia Impairs Glucose Homeostasis in C57BL6", J Mice: Partial Improvement with Cessation of the Exposure, 2013, pp.36(10), 1483~1490[DOI]
  58. Carreras A, "Resveratrol attenuates intermittent hypoxia-induced macrophage migration to visceral white adipose tissue and insulin resistance in male mice", Endocrinology, 156, pp.437~443 (2015)[DOI]
  59. Odegaard JI, "Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis", Science, 339, pp.172~177 (2013)[DOI]
  60. Savransky V, "Chronic intermittent hypoxia predisposes to liver injury", Hepatology, 45, pp.1007~1013 (2007)[DOI]
  61. Li J, "Altered metabolic responses to intermittent hypoxia in mice with partial deficiency of hypoxia-inducible factor-1α", Physiological Genomics, 25, pp.450~457 (2006)[DOI]
  62. Klok MD, "The role of leptin and ghrelin in the regulation of food intake and body weight in humans : a review", Obes Rev, 8, pp.21~34 (2007)[DOI]
  63. Smith SS, "Liking for high fat foods in patients with obstructive sleep apnoea", Appetite, 78, pp.185~192 (2014)[DOI]
  64. Beebe DW, "The association between obstructive sleep apnea and dietary choices among obese individuals during middle to late childhood", Sleep Med, 12, pp.797~799 (2011)[DOI]
  65. Ong CW, "The reciprocal interaction between obesity and obstructive sleep apnoea", Sleep Med Rev, 17, pp.123~131 (2013)[DOI]
  66. Wang Y, "Chronic sleep fragmentation promotes obesity in young adult mice", Obesity(Silver Spring), 22, pp.758~762 (2014)[DOI]
  67. Fahed Hakim, "Chronic Sleep Fragmentation During the Sleep Period Induces Hypothalamic Endoplasmic Reticulum Stress and PTP1b-Mediated Leptin Resistance in Male Mice", Sleep, 38(1), pp.31~40 (2015), Oxford University Press (OUP)[DOI]
  68. Farré R, "Morbidity due to obstructive sleep apnea : insights from animal models", Curr Opin Pulm Med, 14, pp.530~536 (2008)[DOI]
  69. Gozal D, "Sleep, sleep disorders and inflammation in children", Sleep Med, 10(Suppl 1), pp.S12~S16 (2009)[DOI]
  70. Lavie L, "Molecular mechanisms of cardiovascular disease in OSAHS : the oxidative stress link", Eur Respir J, 33, pp.1467~1484 (2009)[DOI]
  71. Valleggi S, "C-reactive protein adversely alters the protein-protein interaction of the endothelial isoform of nitric oxide synthase", Clin Chem, 56, pp.1345~1348 (2010)[DOI]
  72. Yokoe T, "Elevated levels of c-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure", Circulation, 107, pp.1129~1134 (2003)[DOI]
  73. Mehra R, "Soluble interleukin 6 receptor : a novel marker of moderate to severe sleep-related breathing disorder", Archives of Internal Medicine, 166, pp.1725~1731 (2006)[DOI]
  74. Gozal D, "Systemic inflammation in non-obese children with obstructive sleep apnea", Sleep Med, 9, pp.254~259 (2008)[DOI]
  75. Kritchevsky SB, "Inflammatory markers and cardiovascular health in older adults", Cardiovasc Res, 66, pp.265~275 (2005)[DOI]
  76. McNicholas WT, "Obstructive sleep apnea and inflammation", Progress in Cardiovascular Diseases, 51, pp.392~399 (2009)[DOI]
  77. David Gozal, "Cardiovascular Morbidity in Obstructive Sleep Apnea", American Journal of Respiratory and Critical Care Medicine, 177(4), pp.369~375 (2008), American Thoracic Society[DOI]
  78. Dyugovskaya L, "Activated cd8+ t-lymphocytes in obstructive sleep apnoea", European Respiratory Journal, 25, pp.820~828 (2005)[DOI]
  79. Ridker PM, "C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women", N Engl J Med, 342, pp.836~843 (2000)[DOI]
  80. Lusis AJ, "Atherosclerosis", Nature, 407, pp.233~241 (2000)[DOI]
  81. Li AM, "C-reactive protein in children with obstructive sleep apnea and the effects of treatment", Pediatr Pulmonol, 43, pp.34~40 (2008)[DOI]
  82. Kheirandish-Gozal L, "Plasma c-reactive protein in nonobese children with obstructive sleep apnea before and after adenotonsillectomy", J Clin Sleep Med, 2, pp.301~304 (2006)
  83. Guilleminault C, "C-reactive protein and sleep-disordered breathing", Sleep, 27, pp.1507~1511 (2004)[DOI]
  84. Visser M, "Elevated c-reactive protein levels in overweight and obese adults", Jama, 282, pp.2131~2135 (1999)[DOI]
  85. Htoo AK, "Activation of nuclear factor kappab in obstructive sleep apnea : a pathway leading to systemic inflammation", Sleep Breath, 10, pp.43~50 (2006)[DOI]
  86. Eijiro Ohga, "Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1", Journal of Applied Physiology, 94(1), pp.179~184 (2003), American Physiological Society[DOI]
  87. Ciftci TU, "The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome", Cytokine, 28, pp.87~91 (2004)[DOI]
  88. Bingol Z, "Leptin and adiponectin levels in obstructive sleep apnea phenotypes", Biomark Med, 13, pp.865~874 (2019)[DOI]
  89. Badran M, "Alpha lipoic acid improves endothelial function and oxidative stress in mice exposed to chronic intermittent hypoxia", Oxid Med Cell Longev, 2019, pp.4093018~ (2019)[DOI]
  90. 이석준, "염증 반응과 수면 장애", 대한임상검사과학회지, 47(3), pp.97~104 (2015), 대한임상검사과학회

관련 논문AI추천

이 간행물의 다른 논문 (8건)